612 related articles for article (PubMed ID: 26988240)
41. Focused ultrasound-mediated drug delivery through the blood-brain barrier.
Burgess A; Shah K; Hough O; Hynynen K
Expert Rev Neurother; 2015 May; 15(5):477-91. PubMed ID: 25936845
[TBL] [Abstract][Full Text] [Related]
42. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice.
Choi JJ; Pernot M; Small SA; Konofagou EE
Ultrasound Med Biol; 2007 Jan; 33(1):95-104. PubMed ID: 17189051
[TBL] [Abstract][Full Text] [Related]
43. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
[TBL] [Abstract][Full Text] [Related]
44. Neuromodulation accompanying focused ultrasound-induced blood-brain barrier opening.
Chu PC; Liu HL; Lai HY; Lin CY; Tsai HC; Pei YC
Sci Rep; 2015 Oct; 5():15477. PubMed ID: 26490653
[TBL] [Abstract][Full Text] [Related]
45. Ultrasound focusing using magnetic resonance acoustic radiation force imaging: application to ultrasound transcranial therapy.
Hertzberg Y; Volovick A; Zur Y; Medan Y; Vitek S; Navon G
Med Phys; 2010 Jun; 37(6):2934-42. PubMed ID: 20632605
[TBL] [Abstract][Full Text] [Related]
46. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles.
Deng J; Huang Q; Wang F; Liu Y; Wang Z; Wang Z; Zhang Q; Lei B; Cheng Y
J Mol Neurosci; 2012 Mar; 46(3):677-87. PubMed ID: 21861133
[TBL] [Abstract][Full Text] [Related]
47. Influence of Nanobubble Concentration on Blood-Brain Barrier Opening Using Focused Ultrasound Under Real-Time Acoustic Feedback Control.
Cheng B; Bing C; Xi Y; Shah B; Exner AA; Chopra R
Ultrasound Med Biol; 2019 Aug; 45(8):2174-2187. PubMed ID: 31072657
[TBL] [Abstract][Full Text] [Related]
48. Establishing sheep as an experimental species to validate ultrasound-mediated blood-brain barrier opening for potential therapeutic interventions.
Pelekanos M; Leinenga G; Odabaee M; Odabaee M; Saifzadeh S; Steck R; Götz J
Theranostics; 2018; 8(9):2583-2602. PubMed ID: 29721100
[No Abstract] [Full Text] [Related]
49. Safety evaluation of frequent application of microbubble-enhanced focused ultrasound blood-brain-barrier opening.
Tsai HC; Tsai CH; Chen WS; Inserra C; Wei KC; Liu HL
Sci Rep; 2018 Dec; 8(1):17720. PubMed ID: 30531863
[TBL] [Abstract][Full Text] [Related]
50. A new safety index based on intrapulse monitoring of ultra-harmonic cavitation during ultrasound-induced blood-brain barrier opening procedures.
Novell A; Kamimura HAS; Cafarelli A; Gerstenmayer M; Flament J; Valette J; Agou P; Conti A; Selingue E; Aron Badin R; Hantraye P; Larrat B
Sci Rep; 2020 Jun; 10(1):10088. PubMed ID: 32572103
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic analysis and drug delivery efficiency of the focused ultrasound-induced blood-brain barrier opening in non-human primates.
Samiotaki G; Karakatsani ME; Buch A; Papadopoulos S; Wu SY; Jambawalikar S; Konofagou EE
Magn Reson Imaging; 2017 Apr; 37():273-281. PubMed ID: 27916657
[TBL] [Abstract][Full Text] [Related]
52. Quality assurance for focused ultrasound-induced blood-brain barrier opening procedure using passive acoustic detection.
Chien CY; Xu L; Yuan J; Fadera S; Stark AH; Athiraman U; Leuthardt EC; Chen H
EBioMedicine; 2024 Apr; 102():105066. PubMed ID: 38531173
[TBL] [Abstract][Full Text] [Related]
53. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.
Chen PY; Hsieh HY; Huang CY; Lin CY; Wei KC; Liu HL
J Transl Med; 2015; 13():93. PubMed ID: 25784614
[TBL] [Abstract][Full Text] [Related]
54. Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening.
Ji R; Karakatsani ME; Burgess M; Smith M; Murillo MF; Konofagou EE
J Control Release; 2021 Sep; 337():458-471. PubMed ID: 34324895
[TBL] [Abstract][Full Text] [Related]
55. Claudin-5 binder enhances focused ultrasound-mediated opening in an
Chen L; Sutharsan R; Lee JL; Cruz E; Asnicar B; Palliyaguru T; Wasielewska JM; Gaudin A; Song J; Leinenga G; Götz J
Theranostics; 2022; 12(5):1952-1970. PubMed ID: 35265192
[No Abstract] [Full Text] [Related]
56. Folate-conjugated gene-carrying microbubbles with focused ultrasound for concurrent blood-brain barrier opening and local gene delivery.
Fan CH; Chang EL; Ting CY; Lin YC; Liao EC; Huang CY; Chang YC; Chan HL; Wei KC; Yeh CK
Biomaterials; 2016 Nov; 106():46-57. PubMed ID: 27544926
[TBL] [Abstract][Full Text] [Related]
57. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.
Chen CC; Sheeran PS; Wu SY; Olumolade OO; Dayton PA; Konofagou EE
J Control Release; 2013 Dec; 172(3):795-804. PubMed ID: 24096019
[TBL] [Abstract][Full Text] [Related]
58. Focused ultrasound phantom model for blood brain barrier disruption.
Alekou T; Giannakou M; Damianou C
Ultrasonics; 2021 Feb; 110():106244. PubMed ID: 32942090
[TBL] [Abstract][Full Text] [Related]
59. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
[TBL] [Abstract][Full Text] [Related]
60. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
